Research news

Search news

Browse by category

Browse:

Select all - Clear all

MIPS and Thermo Fisher announce ‘GPCR Cryo-EM and Drug Design’ collaboration

A new collaboration between MIPS researcher Professor Patrick Sexton’s team and the leading biological cryo-EM biotechnology product development company, Thermo Fisher Scientific, will bring cryo-electron microscopy of G protein-coupled

Old fashioned may be the safest bet: Monash researchers find that paracetamol works best for pain relief

Research by the Centre for Medicine Use and Safety at Monash University in collaboration with the Department of Emergency Medicine, Auckland Hospital in New Zealand has found that paracetamol alone is just as effective as combining opioids and

MIPS maintains top score in 2018 ERA rankings

The Monash Institute of Pharmaceutical Sciences has again received excellent results in the latest Excellence in Research for Australia (ERA) rankings.

Monash University news

Technology based on Monash research licensed by PureTech Health to Boehringer Ingelheim

Collaboration will use technology licensed to PureTech Health to develop Boehringer Ingelheim’s novel immuno-oncology product candidates

US biopharmaceutical company licenses Monash University 'superbug' drug discovery

Monash University announced today the grant of an exclusive licence of its portfolio of proprietary synthetic polymyxin antibiotics to Qpex Biopharma, a US-based biopharmaceutical company focused on developing new antibiotics to combat the

Denise

Breakthrough could lead to better drugs to tackle diabetes and obesity

Breakthrough research at Monash University has shown how different areas of major diabetes and obesity drug targets can be ‘activated’, guiding future drug development and better treatment of diseases.

Medicine & health
Associate Professor Bernard Flynn

From lab to industry, Monash-linked start up attracts $7M investment

Drug discovery research at Monash has underpinned a new spin out company to develop therapies for metabolic syndrome and type-2 diabetes-related diseases.

Medicine & health

Monash led study of 1000+ heavy smokers reveals an undiagnosed burden of COPD

Chronic obstructive pulmonary disease (COPD) is the fifth leading cause of death in Australia, with 7.5% of Australians over the age of 40 years experiencing moderate to severe forms of the disease. Smoking is the main cause of COPD, with as many

Faculty success in major Commonwealth grant programs

The Monash Faculty of Pharmacy and Pharmaceutical Sciences has been awarded nearly $20 million dollars in research funding in the recent rounds of grants announced by the National Health and Medical Research Council (“NHMRC”) and the